Universe · entity
DAFNA Capital Management LLC
Institutional manager (13F) · CIK 1389933
13F holdings · as of 2026-03-31 · top 50 · reported portfolio $413M
| # | Issuer | Value | Shares |
|---|---|---|---|
| 1 | REVOLUTION MEDICINES INC | $56M | 580,678 |
| 2 | SPDR S&P BIOTECH ETF | $41M | 318,505 |
| 3 | STEREOTAXIS INC | $25M | 13,680,554 |
| 4 | DAY ONE BIOPHARMACEUTICALS I | $21M | 978,463 |
| 5 | ATRICURE INC | $17M | 597,431 |
| 6 | IDEAYA BIOSCIENCES INC | $16M | 476,740 |
| 7 | XENON PHARMACEUTICALS INC | $15M | 250,772 |
| 8 | CYTOKINETICS INC | $14M | 217,497 |
| 9 | COMPASS PATHWAYS PLC | $13M | 2,418,882 |
| 10 | NEKTAR THERAPEUTICS | $12M | 165,178 |
| 11 | ISHARES NASDAQ BIOTECH INDX | $10M | 62,095 |
| 12 | ARCUS BIOSCIENCES INC | $10M | 443,829 |
| 13 | NEUROCRINE BIOSCIENCES INC | $9M | 70,615 |
| 14 | LARIMAR THERAPEUTICS INC | $9M | 2,029,164 |
| 15 | BICARA THERAPEUTICS INC | $8M | 421,733 |
| 16 | AXOGEN INC | $8M | 249,960 |
| 17 | BIOHAVEN LTD | $7M | 845,735 |
| 18 | TANDEM DIABETES CARE INC | $7M | 355,208 |
| 19 | DENALI THERAPEUTICS INC | $6M | 318,500 |
| 20 | ASCENDIS PHARMA A/S | $6M | 4,000,000 |
| 21 | CENTURY THERAPEUTICS INC | $6M | 2,434,353 |
| 22 | DEXCOM INC | $5M | 86,279 |
| 23 | KALVISTA PHARMACEUTICALS INC | $5M | 267,402 |
| 24 | ASCENDIS PHARMA A/S | $5M | 23,177 |
| 25 | MBX BIOSCIENCES INC | $5M | 175,465 |
| 26 | INOGEN INC | $5M | 845,179 |
| 27 | SYNDAX PHARMACEUTICALS INC | $5M | 217,355 |
| 28 | ALKERMES PLC | $5M | 139,482 |
| 29 | STOKE THERAPEUTICS INC | $4M | 130,875 |
| 30 | BIOCRYST PHARMACEUTICALS INC | $4M | 430,248 |
| 31 | GALAPAGOS NV | $4M | 130,175 |
| 32 | IMMUNOVANT INC | $4M | 150,524 |
| 33 | EDGEWISE THERAPEUTICS INC | $4M | 112,236 |
| 34 | MAPLIGHT THERAPEUTICS INC | $3M | 171,006 |
| 35 | ALLOGENE THERAPEUTICS INC | $3M | 1,370,118 |
| 36 | PROCEPT BIOROBOTICS CORP | $3M | 120,000 |
| 37 | ALIGN TECHNOLOGY INC | $3M | 15,000 |
| 38 | PROQR THERAPEUTICS N V | $3M | 1,567,561 |
| 39 | CYBIN INC | $2M | 498,361 |
| 40 | RAPPORT THERAPEUTICS INC | $2M | 75,000 |
| 41 | INSULET CORP | $2M | 10,870 |
| 42 | STRUCTURE THERAPEUTICS INC | $2M | 46,500 |
| 43 | IMMATICS NV | $2M | 225,860 |
| 44 | CELLDEX THERAPEUTICS INC | $2M | 68,518 |
| 45 | LEXEO THERAPEUTICS INC | $2M | 377,059 |
| 46 | ALECTOR INC | $2M | 908,351 |
| 47 | VIKING THERAPEUTICS INC | $2M | 59,516 |
| 48 | KURA ONCOLOGY INC | $2M | 235,868 |
| 49 | PROFOUND MEDICAL CORP | $2M | 263,005 |
| 50 | FULCRUM THERAPEUTICS INC | $2M | 205,000 |
Source: sec_edgar_13f · public regulatory · retrieved 2026-06-29. Public SEC data; no contact information.